Skip to main content

Home/ MaRS/ Group items tagged partner

Rss Feed Group items tagged

Assunta Krehl

Tim Jackson: Entrepreneurship and the upside to a downturn - The Globe and Mail - 0 views

  •  
    Tim Jackson is a partner at Tech Capital Partners and states his views on how he believes venture capital is at a shortage and people need to reinvest. He mentions how entrepreneurs need to network with Communitech, Ottawa Centre for Research and Innovation and MaRS.
  •  
    Tim Jackson is a partner at Tech Capital Partners and states his views on how he believes venture capital is at a shortage and people need to reinvest. He mentions how entrepreneurs need to network with Communitech, Ottawa Centre for Research and Innovation and MaRS. April 6, 2009
Assunta Krehl

BMW Canada named official green transportation partner for 2009 Allstream Global Forum:... - 0 views

  •  
    MTS Allstream Inc. ("MTS Allstream") announced that BMW Canada is the official green transportation partner for the 2009 Allstream Global Forum: An Evening with Vice President Al Gore, taking place on November 24, 2009 at the Allstream Centre in Toronto. MaRS Discovery District is one of the partners for the 2009 Allstream Global Forum. Nov 12, 2009
Karen Schulman Dupuis

Mindr Mobile | Mindr Mobile, National Council of Women of Canada partner on Smartphone ... - 0 views

  •  
    Mindr Mobile, National Council of Women of Canada partner on Smartphone application aimed to increase personal safety
kathryn mars

The NIH: An Attractive Partner for Collaboration - 0 views

  •  
    The NIH Partner Collaboration slideshow from the MaRS Best Practices event. Speaker/Presenter: Mukul Ranjan, Ph.D, Office of Technology Development, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
Cathy Bogaart

Waterloo Region Economic Development - Canada's Technology Triangle - Waterloo, Ontario... - 0 views

  •  
    Canada's Technology Triangle Inc (CTT) is a not-for-profit, public-private regional economic development partnership that markets the competitive advantages of the Waterloo Region to the world, and works to attract new businesses, investment and talent to the Region. As an information provider and business network facilitator, CTT is typically the first point of contact for enterprises outside the Waterloo Region interested in start-up, expansion, or relocation to the Waterloo Region. CTT's activity complements its partner municipalities, who focus on local business retention and expansion, and investment-related site location, business cost, servicing, and development approval considerations. CTT's municipal partners are the cities of Cambridge, Kitchener and Waterloo, and the townships of North Dumfries, Wellesley, Wilmot and Woolwich.
Assunta Krehl

Pharmafocus.com - 0 views

  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  •  
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

Mount Sinai Services - 0 views

  • Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners
  •  
    Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners.
  •  
    Mount Sinai Services (MSS) provides an extensive set of custom laboratory research services for researchers, pharmaceutical companies and other industry partners
Assunta Krehl

YSEC partner with SIG@MaRS for Revision 2010! - Re:Vision 2010 Conference - March 22, 2010 - 1 views

  •  
    SIG@MaRS partners with YSEC for their inaugural conference.
Assunta Krehl

Energy Storage: A Key Smart Grid Component - Smart Grid - 0 views

  •  
    On Nov 4, there was a presentation that took place at the MaRS Centre on Energy Storage Market. The session was moderated by Deloitte's director of research, Duncan Stewart. Other speakers were: Sankar Das Gupta, CEO of Toronto-based Electrovaya, Mark Tinkler, principal consultant of Emerging Energy Options, Kirk Washington, general partner at Yaletown Venture Partners, and Ken Rudisuela, president of Mobilogy Inc. The seminar focused on the importance of energy storage, not just to make renewable energy more practical, but also to reduce our dependency on carbon-based fuel, especially gasoline. Nov 5, 2009
Assunta Krehl

MaRS Launches JOLT, Canada's Newest Startup Accelerator Venture Capital, Private Equit... - 1 views

  •  
    Headed by Executive Director, Susan McGill, JOLT will select up to 15 high-potential startups annually, providing them with space, seed financing and mentorship, as well as access to partners and some of the top angel and venture capital investors in the industry.
  •  
    MaRS announced the creation of JOLT, a new technology accelerator dedicated to building high-growth web and mobile companies that promise to transform the way consumers and enterprises connect, work and play. JOLT will select up to 15 high-potential startups annually, providing them with space, seed financing and mentorship, as well as access to partners and some of the top angel and venture capital investors in the industry. The goal of the program is to accelerate market validation and, in turn, help these companies secure the capital and talent necessary to scale efficiently.
Assunta Krehl

The Transition Year - BioscienceWorld - 0 views

  •  
    Tony Cruz, Founder and CEO of Transition Therapeutics plans to be looking to partner some its products and be on the US stock exchange.
  •  
    Tony Cruz, Founder and CEO of Transition Therapeutics plans to be looking to partner some its products and be on the US stock exchange. Sept 1, 2006
Assunta Krehl

MobileMonday Toronto Launches Mobile Marketing Awards Competition September 8th - Marke... - 0 views

  • On September 8th, MobileMonday Toronto, Toronto's premier networking event for mobile industry professionals, will be hosting its first annual MobileMonday Toronto Marketing Awards. This event was set up to recognize Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel.
  • Since announcing the partnership with MaRS in February 2009, MobileMonday Toronto has experienced explosive growth with monthly attendance exceeding 250+ attendees and has received general appreciation for the chapter's approach to support all stakeholders within the mobile industry which includes telecom providers, device manufacturers, startups, venture capital and developers in addition to many industry verticals such as search, m-commerce, advertising, and media.
  • The first annual MobileMonday Toronto Marketing Awards will be held on Tuesday September 8th (due to Labour Day holiday) at MaRS Discovery District, located at 101 College Street (south east corner of College and University). The event starts at 6:30pm. To RSVP for this event, please visit www.mobilemondaytoronto.com.
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizse Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel. Sept 2, 2009
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel. Sept 2, 2009
Assunta Krehl

MobileMonday Celebrates Tuesday with Awards Gala - eSource Canada Business News Network - 0 views

  • MobileMonday Toronto, Toronto's premier networking event for mobile industry professionals, will be hosting its first annual MobileMonday Toronto Marketing Awards on Tuesday, September 8th, 2009The event recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel.
  • Since announcing the partnership with MaRS in February 2009, MobileMonday Toronto has experienced explosive growth with monthly attendance exceeding 250+ attendees and has received general appreciation for the chapter's approach to support all stakeholders within the mobile industry which includes telecom providers, device manufacturers, startups, venture capital and developers in addition to many industry verticals such as search, m-commerce, advertising, and media.
  • The first annual MobileMonday Toronto Marketing Awards will be held on Tuesday September 8th (due to Labour Day holiday) at MaRS Discovery District, located at 101 College Street (south east corner of College and University). The event starts at 6:30pm.
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel.
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel. Sept 5, 2009
Assunta Krehl

reportonbusiness.com: THE COMPANY: INFONAUT INC.: Charting the right course through an ... - 0 views

  • Toronto, where a small firm is using 21st-century software to create maps with similar goals - the containment of disease - by showing infection patterns that can be understood at a glance.
  • Toronto, where a small firm is using 21st-century software to create maps with similar goals - the containment of disease - by showing infection patterns that can be understood at a glance.
  • There's nothing wrong with Infonaut using the H1N1 flu outbreak to gain exposure, as long as the company is careful in the tone it takes, said John Lute, president of Toronto communications firm Lute and Co.
  • ...15 more annotations...
  • Infonaut Inc. chief executive officer Niall Wallace and his partner, chief operating officer Matt McPherson, both former IT consultants for the Ontario government, created the company after helping to craft some of the recommendations that resulted from the SARS outbreak of 2003. They understood the value of visually represented, real-time infection data, and left government to set up Infonaut to develop that technology.
  • Infonaut has created three software products that turn infection information into maps. All are being tested in pilot projects and will soon be marketed commercially.
  • One, called Infection Watch Live, is now taking data gathered at 14 hospital emergency rooms in eastern Ontario and using it to create publicly accessible maps that show exactly where in the region cases of influenza and gastrointestinal diseases are active.
  • This complex mapping can help monitor and stop the spread of C. difficile and other superbugs.
  • The third product, called Regional Watch Live, generates maps and reports for regional health professionals by merging lab test results with a range of other information.
  • INFONAUT INC
  • Make sure to present straightforward information about how the company's products might help mitigate an outbreak in the future, but do not exaggerate promises. Be upfront about the state of pilot tests, the timelines to get the software to market, and how much funding will be needed to go to full commercialization. Use respected third-party partners to endorse the products, a move that will give the company more credibility. If there are privacy concerns, spell them out and detail how they are being addressed.
  • Infonaut should ensure that its message is understated and that the company is not an "ambulance chaser," Mr. Lute said
  • But the company does need to give straightforward information about how its products might help mitigate an outbreak in the future, and not exaggerate its promises, she said. In particular, it needs to be upfront about the state of its pilot tests and include details of when full versions of its products will be available. It also must explain how much funding they will need to get there, Ms. Wilcox said.
  • With Infonaut, there seems to be no question that there is a public gain, he said. "If it is just an opportunistic attempt to cash in on the misfortune of others, that tends to play badly. Where a company has something that can be tied to the public interest, such as in this case ... it is very low-risk."
  • He suggests that Infonaut make good use of its pilot test partners, such as the counties in eastern Ontario that are testing the Infection Watch Live system.
  • the company should forestall any concerns over privacy issues by spelling out how it ensures data on individuals are kept confidential.
  • There's nothing wrong with using the current concerns over H1N1 flu to gain exposure, as long as Infonaut is careful about taking a calm and respectful tone to its marketing and publicity.
  • On the other hand, it will clearly create an opportunity if Infonaut can increase its profile, "which helps it to get its story out, which helps it to get investors, which helps it to grow.
  • The problem Build a market for a unique infection mapping system without appearing to exploit the flu outbreak The plan: Use a subtle approach and be upfront with the state of development of the software products The payoff: Higher awareness among potential customers and an expanded market
  •  
    Using 21st-century Infonaut is using software to create maps - the containment of disease - by showing infection patterns that can be understood at a glance.
Assunta Krehl

Toronto's $25 million commercialization "engine" celebrates the appointment of its Boar... - 0 views

  • MaRS Innovation is honoured to announce its permanent Board of Directors, who brings together a remarkable and broad set of experiences and networks to support the development of this dynamic partnership of Toronto research institutions.  Designed to enhance the commercial output of Toronto’s world-leading research cluster, MaRS Innovation is positioned to make a significant contribution to Canada’s innovation economy and the quality of life for Canadians and others around the world.
  • upported by the Government of Canada through the Centres of Excellence in Research and Commercialization (CECR) program, and its member institutions, MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. The newly appointed Board of Directors, which includes academic and business leaders from across Canada and the United States, has the targeted expertise to guide MaRS Innovation to deliver on this critical mission.   MaRS Innovation represents a unique collaborative model, which aggregates the exceptional discovery pipeline of 14 leading Toronto academic institutions to build a diversified portfolio of assets, and harness the economic and job creation potential of the best opportunities for Toronto, Ontario and Canada.
  • “MaRS Innovation is privileged to announce a Board of Directors of this caliber and breadth of skill,” said Mary Jo Haddad, Chair of the MaRS Innovation Board and President and CEO of The Hospital for Sick Children. “The collective experience and guidance of these individuals will be critical to developing a collaborative, integrated and agile approach to this transformational organization that will move Canada into its next phase of economic development.”
  • ...2 more annotations...
  • W. Geoffrey Beattie – Deputy Chairman & President, Woodbridge Company Limited, Thomson Reuters Corporation, Toronto Christopher C. Capelli – Vice President, Technology Based Ventures, Office of Technology Commercialization, University of Texas, M.D. Anderson Cancer Center, Houston, TX Ron Close – Information technology entrepreneur, Entrepreneur-in-Residence, MaRS, and Executive Entrepreneur-in-Residence, The Richard Ivey School of Business, The University of Western Ontario, London, ON Nicholas Darby – Formerly Director of Physical Sciences, Corporate Venture Capital, Dow Chemical Company, President, Darby & Associates Consulting LLC, Midland, MI  Mary Jo Haddad – President & CEO, The Hospital for Sick Children, Toronto Jacqueline H.R. Le Saux – Former General Counsel, North America and Corporate Secretary, Patheon, Inc., Toronto David A. Leslie - Chair, Sunnybrook Health Sciences Centre, and Former Chairman & CEO, Ernst & Young, Toronto Michael H. May – President & CEO, Rimon Therapeutics, Toronto Chandra J. Panchal – Founder, President & CEO, Axcelon Biopolymers Corp., Dollard-des-Ormeaux, QC Ilse Treurnicht – CEO, MaRS Discovery District, Toronto Donald A. Wright – President & CEO, The Winnington Capital Group Inc., Toronto
  • MaRS Innovation serves as a business accelerator platform with a single point of entry for industry partners and investors.  It will increase the scale, scope and viability of IP offerings, and the quantity and quality of deal flow from partner institutions.  MaRS Innovation will also facilitate strategic research collaborations with industry partners, strengthen the innovation capacity of Canadian industry through adoption of new technologies from its member institutions, and launch a new generation of robust, high-growth Canadian companies that will become global market leaders.   The quality of the combined discovery pipeline will catalyze and attract sources of risk capital for translational research, market validation, company formation and growth.  “MaRS Innovation represents a unique and timely platform to contribute in a meaningful way to Canada’s knowledge economy, leveraging Toronto’s remarkable research excellence.  The vision and serious commitment of its members to work together to transform our commercialization results, and the support of the Federal Government, made this possible.  The announcement of this outstanding group of leaders to the Board of Directors for MaRS Innovation is an exciting step forward,” said Ilse Treurnicht, MaRS CEO and interim Managing Director of MaRS Innovation.
  •  
    MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs.
  •  
    MaRS Innovation announced its permanent Board of Directors. MaRS Innovation is focused on converting important discoveries into a new generation of products, services and high value jobs. Feb 6, 2009
Assunta Krehl

Innovation Overhaul- Idea Couture and MaRS Partner To Remodel MaRS Website - PR Web - J... - 1 views

  •  
    Idea Couture and MaRS Discovery District, two companies at the forefront of innovation, have successfully partnered to remodel and reinvigorate the MaRS online experience.
Cathy Bogaart

Marketing your Small Business Brand, Venture Accelerator Partners, Feb 24, 2011 - 0 views

  •  
    Venture Accelerator Partners recap and summarize the Entrepreneurship 101 lecture on Marketing with guest lecturer, Mark Evans.
Assunta Krehl

MTS Allstream and MaRS partner to showcase innovative green technologies at the 2009 Al... - 0 views

  •  
    "MTS Allstream Inc. ("MTS Allstream") has partnered with MaRS Discovery District ("MaRS") - a leading innovation centre that supports Canadian innovation by connecting science, technology and social entrepreneurs with business skills and capital. MaRS will showcase new and dynamic green technologies at the 2009 Allstream Global Forum: An Evening with Vice President Al Gore being held November 24 at the Allstream Centre, Toronto. "MaRS will showcase the following three emerging Canadian companies at this year's "Green Gallery of Innovation": Echologics Engineering Inc.,Skymeter Corp., and Clean Energy Developments. Nov 6, 2009
Assunta Krehl

Startup and small business events you don't want to miss in October 2011 - Venture Acce... - 1 views

  •  
    The Venture Accelerator Partners posted a blog with a listing of events that would be useful for start-ups and small businesses. The How Open Source Can Ensure Success for Technology Start-ups on October 11 and the Basic Nuts and Bolts of Building a Business on October 19 events were both mentioned.
1 - 20 of 87 Next › Last »
Showing 20 items per page